Simin Wang , Yanli Zhang , Yuting Zeng , Xin Luo , Jiaping Chen , Qianwen Deng , Ping Xiao , Ruofei Lin , Xiuwen Chen , Xian Ding , Qianlin Li , Sijie Qiu , Dehong Yang , Wenjuan Yan
{"title":"植物源性囊泡样纳米颗粒免疫调节:机制和应用","authors":"Simin Wang , Yanli Zhang , Yuting Zeng , Xin Luo , Jiaping Chen , Qianwen Deng , Ping Xiao , Ruofei Lin , Xiuwen Chen , Xian Ding , Qianlin Li , Sijie Qiu , Dehong Yang , Wenjuan Yan","doi":"10.1016/j.bioactmat.2025.09.024","DOIUrl":null,"url":null,"abstract":"<div><div>Immune dysregulation can result in sustained activation of the immune system, leading to systemic chronic inflammation. This condition significantly disrupts immune homeostasis and is intimately associated with the onset of numerous chronic systemic diseases. Currently, the treatment of diseases related to immune dysregulation confronts several challenges, most notably the substantial side effects and inconsistent efficacy of long-term immunosuppressive drug use. Consequently, developing immunomodulatory strategies that balance efficacy and safety has emerged as a prominent research focus. Plant-derived vesicle-like nanoparticles (PVLNs), natural nanomaterials secreted by plant cells, exhibit significant potential in immunomodulation owing to their excellent biocompatibility, minimal immunogenicity, and cross-species communication capabilities. This paper reviews the biogenesis, composition, and properties of PVLNs, emphasizing the mechanisms of innate and adaptive immunomodulation they mediate and their applications in diseases characterized by immune disorders. It also analyzes the challenges related to target delivery, stability optimization, drug loading, and storage encountered in their engineering. In the future, as the mechanisms of PVLNs are more deeply understood and nanotechnology continues to advance, their potential in precision immunotherapy and clinical translation is anticipated to be further augmented.</div></div>","PeriodicalId":8762,"journal":{"name":"Bioactive Materials","volume":"55 ","pages":"Pages 171-204"},"PeriodicalIF":18.0000,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Plant-derived vesicle-like nanoparticles for immunomodulation: Mechanisms and applications\",\"authors\":\"Simin Wang , Yanli Zhang , Yuting Zeng , Xin Luo , Jiaping Chen , Qianwen Deng , Ping Xiao , Ruofei Lin , Xiuwen Chen , Xian Ding , Qianlin Li , Sijie Qiu , Dehong Yang , Wenjuan Yan\",\"doi\":\"10.1016/j.bioactmat.2025.09.024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Immune dysregulation can result in sustained activation of the immune system, leading to systemic chronic inflammation. This condition significantly disrupts immune homeostasis and is intimately associated with the onset of numerous chronic systemic diseases. Currently, the treatment of diseases related to immune dysregulation confronts several challenges, most notably the substantial side effects and inconsistent efficacy of long-term immunosuppressive drug use. Consequently, developing immunomodulatory strategies that balance efficacy and safety has emerged as a prominent research focus. Plant-derived vesicle-like nanoparticles (PVLNs), natural nanomaterials secreted by plant cells, exhibit significant potential in immunomodulation owing to their excellent biocompatibility, minimal immunogenicity, and cross-species communication capabilities. This paper reviews the biogenesis, composition, and properties of PVLNs, emphasizing the mechanisms of innate and adaptive immunomodulation they mediate and their applications in diseases characterized by immune disorders. It also analyzes the challenges related to target delivery, stability optimization, drug loading, and storage encountered in their engineering. In the future, as the mechanisms of PVLNs are more deeply understood and nanotechnology continues to advance, their potential in precision immunotherapy and clinical translation is anticipated to be further augmented.</div></div>\",\"PeriodicalId\":8762,\"journal\":{\"name\":\"Bioactive Materials\",\"volume\":\"55 \",\"pages\":\"Pages 171-204\"},\"PeriodicalIF\":18.0000,\"publicationDate\":\"2025-09-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bioactive Materials\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2452199X2500430X\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioactive Materials","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2452199X2500430X","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
Plant-derived vesicle-like nanoparticles for immunomodulation: Mechanisms and applications
Immune dysregulation can result in sustained activation of the immune system, leading to systemic chronic inflammation. This condition significantly disrupts immune homeostasis and is intimately associated with the onset of numerous chronic systemic diseases. Currently, the treatment of diseases related to immune dysregulation confronts several challenges, most notably the substantial side effects and inconsistent efficacy of long-term immunosuppressive drug use. Consequently, developing immunomodulatory strategies that balance efficacy and safety has emerged as a prominent research focus. Plant-derived vesicle-like nanoparticles (PVLNs), natural nanomaterials secreted by plant cells, exhibit significant potential in immunomodulation owing to their excellent biocompatibility, minimal immunogenicity, and cross-species communication capabilities. This paper reviews the biogenesis, composition, and properties of PVLNs, emphasizing the mechanisms of innate and adaptive immunomodulation they mediate and their applications in diseases characterized by immune disorders. It also analyzes the challenges related to target delivery, stability optimization, drug loading, and storage encountered in their engineering. In the future, as the mechanisms of PVLNs are more deeply understood and nanotechnology continues to advance, their potential in precision immunotherapy and clinical translation is anticipated to be further augmented.
Bioactive MaterialsBiochemistry, Genetics and Molecular Biology-Biotechnology
CiteScore
28.00
自引率
6.30%
发文量
436
审稿时长
20 days
期刊介绍:
Bioactive Materials is a peer-reviewed research publication that focuses on advancements in bioactive materials. The journal accepts research papers, reviews, and rapid communications in the field of next-generation biomaterials that interact with cells, tissues, and organs in various living organisms.
The primary goal of Bioactive Materials is to promote the science and engineering of biomaterials that exhibit adaptiveness to the biological environment. These materials are specifically designed to stimulate or direct appropriate cell and tissue responses or regulate interactions with microorganisms.
The journal covers a wide range of bioactive materials, including those that are engineered or designed in terms of their physical form (e.g. particulate, fiber), topology (e.g. porosity, surface roughness), or dimensions (ranging from macro to nano-scales). Contributions are sought from the following categories of bioactive materials:
Bioactive metals and alloys
Bioactive inorganics: ceramics, glasses, and carbon-based materials
Bioactive polymers and gels
Bioactive materials derived from natural sources
Bioactive composites
These materials find applications in human and veterinary medicine, such as implants, tissue engineering scaffolds, cell/drug/gene carriers, as well as imaging and sensing devices.